RA patients were then segregated according DAS28 scores into low (DAS28 ≤ 4), moderate (DAS28: 5–7) and high (DAS28 > 7) disease activity states and their CD8+ T cells were analyzed for expression of both TLR4 mRNA transcript and surface protein. The gene discussed is CD8A; the disease is rheumatoid arthritis.